Decently, a Manchester, UK-based provider of a healthcare platform which helps to increase the safety of patients recovering from brain injury, raised £500k in funding.
Backers included the GMC Life Sciences Fund by Praetura, which is supported by the Greater Manchester Combined Authority, Cheshire & Warrington LEP and Bruntwood SciTech, with SFC Capital participating in the round. Jessica Jackson, investment manager at Praetura Ventures, is joining Decently’s board as an investment director.
The creators of a new healthcare platform called Melo, which helps clinicians and hospital staff to track patients’ behaviour whilst they recover from brain trauma, have raised £500k to address potentially adverse episodes in healthcare settings.
Manchester-based Founded in 2021 by James Burch and James Chapman, who boast 20 years health and education tech experience, Decently provides Melo, which works by simplifying and streamlining the data capture process and using artificial intelligence to spot trends and behaviour escalation patterns in patients suffering acquired brain injuries (ABI) and injuries caused by non-birth related incidents, such as accidental trauma or a coma. Clinicians upload patient data based on observations and are given a real-time dashboard as well as reporting tools that make sharing information between staff and departments easier, increasing safety, raising accountability and lowering costs.
The company intends to use the funds to launch Melo across the NHS and private rehabilitation care centres, to scale its team and grow awareness of platform, which is already being piloted by three strategic northern NHS Trusts, including the Northern Care Alliance NHS Foundation Trust, Leeds Teaching Hospitals NHS Trust and Liverpool University Hospitals NHS Foundation Trust.
FinSMEs
20/09/2023